Enovis (NYSE:ENOV) Sets New 12-Month Low – Here’s Why

Shares of Enovis Corporation (NYSE:ENOV) reached a new 52-week low during mid-day trading on Thursday. The stock traded as low as $17.16 and last traded at $17.19, with a volume of 170330 shares trading hands. The stock had previously closed at $17.61.

Analyst Ratings Changes

ENOV has been the topic of several analyst reports. BMO Capital Markets set a $27.00 price objective on shares of Enovis in a research note on Tuesday, September 1st. Weiss Ratings raised Enovis from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, July 21st. Zacks Research upgraded Enovis from a “strong sell” rating to a “hold” rating in a research report on Wednesday, July 29th. Canaccord Genuity Group lowered their price objective on Enovis from $50.00 to $45.00 and set a “buy” rating for the company in a research report on Monday, August 17th. Finally, Wells Fargo & Company cut their price objective on Enovis from $39.00 to $33.00 and set an “overweight” rating on the stock in a research note on Wednesday, September 2nd. Ten investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $39.50.

Enovis Stock Performance

The company has a debt-to-equity ratio of 0.84, a current ratio of 1.98 and a quick ratio of 1.00. The company’s 50-day moving average price is $22.21 and its two-hundred day moving average price is $23.36. The company has a market capitalization of $968.86 million, a price-to-earnings ratio of -0.87 and a beta of 1.37.

Enovis (NYSE:ENOV) last released its earnings results on Thursday, August 6th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.85 by $0.05. The business had revenue of $582.78 million for the quarter, compared to analyst estimates of $581.84 million. Enovis had a negative net margin of 47.96% and a positive return on equity of 12.03%. Enovis’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.79 earnings per share. Enovis has set its FY 2026 guidance at 3.520-3.730 EPS. On average, equities research analysts anticipate that Enovis Corporation will post 3.15 EPS for the current fiscal year.

Insider Activity

In other Enovis news, CEO Damien Mcdonald acquired 13,035 shares of the company’s stock in a transaction dated Friday, September 4th. The shares were bought at an average cost of $19.15 per share, with a total value of $249,620.25. Following the purchase, the chief executive officer directly owned 247,077 shares of the company’s stock, valued at $4,731,524.55. This trade represents a 5.57% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Oliver Engert bought 5,140 shares of the business’s stock in a transaction that occurred on Thursday, September 3rd. The shares were acquired at an average price of $19.46 per share, for a total transaction of $100,024.40. Following the transaction, the insider owned 61,238 shares in the company, valued at $1,191,691.48. This represents a 9.16% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders bought 23,293 shares of company stock valued at $449,599. Corporate insiders own 2.90% of the company’s stock.

Hedge Funds Weigh In On Enovis

Institutional investors have recently added to or reduced their stakes in the business. IFP Advisors Inc increased its stake in shares of Enovis by 5,590.5% in the 2nd quarter. IFP Advisors Inc now owns 1,195 shares of the company’s stock valued at $25,000 after acquiring an additional 1,174 shares in the last quarter. Allworth Financial LP acquired a new stake in Enovis in the second quarter worth $36,000. Integrated Wealth Concepts LLC acquired a new stake in Enovis in the second quarter worth $39,000. Public Employees Retirement System of Ohio bought a new stake in Enovis in the second quarter valued at $48,000. Finally, Annis Gardner Whiting Capital Advisors LLC increased its stake in Enovis by 468,400.0% in the first quarter. Annis Gardner Whiting Capital Advisors LLC now owns 4,685 shares of the company’s stock valued at $107,000 after purchasing an additional 4,684 shares in the last quarter. 98.45% of the stock is owned by institutional investors and hedge funds.

Enovis Company Profile

Enovis Corporation is a medical technology company that develops, manufactures and distributes products designed to improve patient outcomes and support the restoration of movement. Its portfolio serves orthopedic, rehabilitation and recovery markets, with products used by physicians, hospitals, physical therapists, athletic trainers and consumers.

The company’s offerings include orthopedic braces and supports, cold and compression therapy systems, rehabilitation equipment, electrical stimulation and ultrasound products, surgical implants and related technologies.